Connecticut and 14 other states on Thursday agreed to a new settlement deal with the Sackler family and Purdue Pharma that would secure $7.4 billion for communities across the United States that have been impacted by the opioid crisis.
Purdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total of $6.5 billion, New York Attorney General Letitia James said Thursday.
Opioid maker Purdue Pharma and members of the Sackler family have reached a tentative deal over their role in the opioid crisis that’s expected to deliver up to $250 million to New York, Attorney General Letitia James said Thursday.
Purdue Pharma and the Sackler family that controls the major prescription opioids manufacturer have agreed to a $7.4 billion settlement with West Virginia and 13 other states due to fueling the substance use disorder crisis.
A $7.4 billion settlement has been reached in principle between states, victims, and members of the Sackler family and Purdue Pharma for their roles in the opioid crisis, Attorney General William Tong said Thursday.
Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the prescription painkiller.
Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of U.S. states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid epidemic.
Several states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis.
It’s among the largest settlements reached over the past several years in a series of lawsuits by local, state, Native American tribal governments and others seeking to hold companies responsible for a deadly epidemic.